Login to Your Account



CERN Spinout AAA Picking Up Speed in Lutathera Trial


Tuesday, September 25, 2012
Advanced Accelerator Applications SA has set itself the challenge of servicing 42 centers across the U.S. and Europe, in a 200-patient Phase III trial of Lutathera, a radiolabeled peptide that has a shelf life of only 72 hours.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription